Akorn Wants Derivative Suit Related To Failed Merger Axed
By Dean Seal ( January 15, 2019, 6:01 PM EST) -- Akorn Inc. told an Illinois federal judge on Monday that a shareholder's consolidated derivative suit claiming the pharmaceutical company's falsified regulatory submissions sunk a multibillion-dollar merger and tanked Akorn's share price doesn't offer allegations to support a securities claim and must be tossed....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.